Complimentary CME Dinner: Oncology Innovations: Applying the Latest Evidence in Extensive-Stage Small Cell Lung Cancer Care
Ruth's Chris Steak House
2321 Lifestyle Way
Chattanooga, TN 37421
Tuesday, March 3, 2026 at 5:45pm ET - 7:15pm ET
Add this event to your calendar
Info
Topic
For decades, treatment outcomes for small cell lung cancer (SCLC) have remained generally poor. But that’s now changing. New treatment agents and combinations are showing promising results, including improving survival. Join us for a complimentary dinner and CME as our experts discuss the latest efficacy and safety data from clinical trials of newly approved and emerging therapies and new therapeutic combinations.
Credits Offered
This event offers
1.25 CME credits
to attendees.
Accreditation Info:
AAPA.
Additional Information
Learning Objectives:
- Assess efficacy and survival data from recent clinical trials supporting the use of new therapies and new therapeutic combinations in patients with ES-SCLC.
- Design strategies to monitor for and manage adverse events associated with novel combination regimens and new and emerging therapies in ES-SCLC.
Target Audience:
All members of the community oncology care team including medical oncologists, nurse practitioners, physician assistants, nurses, pharmacists, and other HCPs involved in the care of patients with SCLC
Educational Objectives
Upon completion of this activity, participants should be able to:
- Assess efficacy and survival data from recent clinical trials supporting the use of new therapies and new therapeutic combinations in patients with ES-SCLC.
- Design strategies to monitor for and manage adverse events associated with novel combination regimens and new and emerging therapies in ES-SCLC.